RxDoctor Payments Data

Robert Kipperman, MD

Cardiovascular Disease · Morristown, NJNPI 1942297908

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $33,370 of the $47,914 with a category attached, or 69.6%. 23 manufacturers reported payments, led by Medtronic at 41.5% of the total. Reporting peaked in 2019 at $14,293 and has fallen 52.2% since, to $6,837 in 2025. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,914in general payments, 2019–2025

Across 919 payments — averaging $52.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$20K
  • Edwards Lifesciences$19K
  • Abbott$5K
  • Boston Scientific$874
  • AOP Health US, LLC$510
  • W. L. Gore & Associates, Inc.$509
  • plus $2K from 17 others
$5,257,407in research payments, 2019–2025

Across 820 payments — averaging $6411.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$4.9M
  • Medtronic$226K
  • Abbott$149K
  • Bayer$5K
  • Livanova USA, Inc.$3K
  • W. L. Gore & Associates, Inc.$1K

What the payments were for

  • Speaking & faculty fees$4,57510%
  • Travel & lodging$9,67220%
  • Food & beverage$33,37070%
  • Entertainment$160%
  • Other$2821%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,914 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$282,307
Medicare patients
513
Services billed
1,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Morristown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →